Silence Therapeutics PLC | Key People and Executives
Andrew John McGlashan Richards
Non-Executive Chairman
David Horn Solomon
Chief Executive Officer & Director
David J. Ellam
CFO, Secretary & Executive Director
David Lemus
Non-Executive Director
Alistair William Gray
Non-Executive Director
Stephen B. Parker
Non-Executive Director
Andrew John McGlashan Richards
Non-Executive Chairman
David Horn Solomon
Chief Executive Officer & Director
David J. Ellam
CFO, Secretary & Executive Director
Marie W. Lindholm
Head-Technology Innovation
Michael Mulqueen
Head-Business Development & Licensing
David Lemus
Non-Executive Director
Linnea Elrington
Director-Human Resources
Alistair William Gray
Non-Executive Director
Stephen B. Parker
Non-Executive Director
| Address |
72 Hammersmith Road
London Greater London W14 8TH
United Kingdom
|
|
Employees
|
- |
| Website |
http://silence-therapeutics.com |
| Updated |
07/08/2019 |
| Silence Therapeutics Plc engages in the development of ribonucleic acid (RNA) therapeutics. It develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. Its proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. |
